What is the management approach for bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Bronchitis

Critical Distinction: Bronchiolitis vs. Acute Bronchitis

The management approach depends entirely on whether you are treating bronchiolitis (viral infection in infants/young children) or acute bronchitis (respiratory infection in adults)—these are fundamentally different conditions requiring opposite approaches.


BRONCHIOLITIS (Infants 1-23 Months)

Diagnosis

  • Diagnose based on history and physical examination alone—do not routinely order laboratory tests or chest radiographs 1
  • Look for rhinitis and cough progressing to tachypnea, wheezing, rales, nasal flaring, and use of accessory muscles 1, 2
  • Assess for risk factors: age <12 weeks, prematurity (<32 weeks gestation), chronic lung disease, hemodynamically significant heart disease, or immunodeficiency 1, 2

Core Management Principles

Supportive care is the cornerstone—most commonly used medications have been proven ineffective:

What NOT to Do:

  • Do not routinely use bronchodilators 1
  • Do not use corticosteroids routinely 1
  • Do not use ribavirin routinely 1
  • Do not use antibiotics unless there is specific evidence of bacterial co-infection 1
  • Do not perform routine chest physiotherapy 1

What TO Do:

Hydration and Feeding:

  • Assess hydration status and ability to take fluids orally 1
  • Offer frequent small feedings, as infants tire easily with nasal congestion and tachypnea 3
  • Hold infant upright during and after feedings 3

Airway Management:

  • Use gentle bulb suction for visible nasal congestion affecting breathing or feeding 3
  • Suction as needed (not on strict schedule), but ensure suctioning occurs at least every 4 hours if significant congestion present 3
  • Avoid deep suctioning—associated with longer illness duration 3
  • Keep head slightly elevated during sleep 3

Oxygen Therapy:

  • Administer supplemental oxygen if SpO2 falls persistently below 90% in previously healthy infants 1
  • Maintain SpO2 at or above 90% with adequate supplemental oxygen 1
  • Discontinue oxygen when SpO2 ≥90%, infant feeds well, and has minimal respiratory distress 1
  • Premature infants and those with hemodynamically significant heart or lung disease require close monitoring during oxygen weaning 1
  • Continuous SpO2 monitoring is not routinely needed as clinical course improves 1

Prevention

Palivizumab Prophylaxis:

  • Administer to infants with hemodynamically significant heart disease or chronic lung disease of prematurity (preterm <32 weeks requiring >21% oxygen for ≥28 days) 1
  • Give 5 monthly doses at 15 mg/kg intramuscularly, typically beginning November/December 1

General Prevention:

  • Hand decontamination before and after patient contact is the most important step in preventing nosocomial spread 1
  • Use alcohol-based hand rubs (preferred) or antimicrobial soap 1
  • Infants should not be exposed to passive smoking 1, 3
  • Breastfeeding decreases risk of lower respiratory tract disease 1
  • Keep infants away from sick contacts and avoid crowded places during RSV season 3

Expected Course

  • Self-limiting illness with most children recovering within 2-3 weeks 2
  • Mean time to cough resolution: 8-15 days 2, 3
  • 90% of children are cough-free by day 21 2

Red Flags Requiring Immediate Evaluation

  • Respiratory rate ≥70 breaths/minute 3
  • Severe feeding difficulty or complete refusal to eat/drink 3
  • Age <12 weeks, prematurity, chronic lung disease, heart disease, or immunodeficiency 2, 3

ACUTE BRONCHITIS (Adults)

Diagnosis

Rule out pneumonia first—this is the critical decision point:

  • In healthy, non-elderly adults, pneumonia is unlikely if ALL of the following are absent: tachycardia (>100 bpm), tachypnea (>24 breaths/min), fever (>38°C), and abnormal chest examination findings (rales, egophony, tactile fremitus) 1
  • Do not order chest radiography in healthy adults without these vital sign abnormalities or asymmetric lung sounds 1
  • Consider chest radiography if cough persists ≥3 weeks without other known cause 1
  • Purulent or colored (green/yellow) sputum does NOT indicate bacterial infection—it reflects inflammatory cells, not bacteria 1, 4

Core Management Principle

Antibiotics are NOT indicated for uncomplicated acute bronchitis—this is the single most important management decision:

  • Do not routinely prescribe antibiotics for acute uncomplicated bronchitis 1
  • More than 90% of cases are viral 1, 4
  • Antibiotics have not been shown to improve clinical outcomes and increase adverse events 1, 4
  • Acute bronchitis leads to more inappropriate antibiotic prescribing than any other respiratory condition in adults 1

When to Consider Antibiotics (Rare Exceptions):

  • Suspected pertussis infection with documented community transmission—perform diagnostic test and initiate antimicrobial therapy 1
  • This is an unusual circumstance and should not drive routine management 1

Symptomatic Treatment Options

Evidence for symptomatic therapies is limited, but options include:

  • Cough suppressants: dextromethorphan or codeine 1
  • Expectorants: guaifenesin 1
  • First-generation antihistamines: diphenhydramine 1
  • Decongestants: phenylephrine 1
  • β-agonists (albuterol): NOT beneficial in patients without asthma or chronic obstructive lung disease 1, 5

Important caveats:

  • Symptomatic therapy has not been shown to shorten illness duration 1
  • Over-the-counter medications have low incidence of minor adverse effects (nausea, vomiting, headache, drowsiness) 1
  • Weigh benefits versus potential adverse effects when considering symptomatic therapy 1

Expected Course

  • Cough typically lasts up to 6 weeks 1
  • Symptoms typically last about 3 weeks 4
  • Self-limited illness in otherwise healthy adults 1, 4

Patient Communication Strategy

  • Patient satisfaction depends on physician-patient communication quality, NOT on antibiotic prescription 1, 6
  • Explain viral etiology and self-limited nature 4, 6
  • Discuss expected symptom duration and when to return if symptoms worsen 4
  • Address antibiotic resistance concerns and lack of benefit 1, 6

Common Pitfalls to Avoid

  • Confusing bronchiolitis (pediatric) with acute bronchitis (adult)—these require completely different management approaches 1, 2
  • Prescribing antibiotics for acute bronchitis based on sputum color or purulence 1, 4
  • Using bronchodilators routinely in bronchiolitis without documented clinical response 1
  • Ordering unnecessary chest radiographs in uncomplicated cases 1
  • Deep nasal suctioning in infants with bronchiolitis 3
  • Continuing oxygen therapy in bronchiolitis when SpO2 is adequate and infant is feeding well 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bronchiolitis in Young Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Bronchiolitis Management and Prevention

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diagnosis and treatment of acute bronchitis.

American family physician, 2010

Research

Diagnosis and management of acute bronchitis.

American family physician, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.